These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29403003)

  • 1. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
    Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
    Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity.
    Kim DH; Choi JM
    BMB Rep; 2018 May; 51(5):207-208. PubMed ID: 29699605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHI3L1 regulates PD-L1 and anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
    Ma B; Akosman B; Kamle S; Lee CM; He CH; Koo JS; Lee CG; Elias JA
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis.
    Ma B; Herzog EL; Moore M; Lee CM; Na SH; Lee CG; Elias JA
    Sci Rep; 2016 May; 6():26299. PubMed ID: 27198666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitinase 3-like-1 deficient donor splenocytes accentuated the pathogenesis of acute graft-versus-host diseases through regulating T cell expansion and type I inflammation.
    Li Z; Gu J; Liu J; Zhu Q; Lu H; Lu Y; Rao J; Lu L; Wang X
    Int Immunopharmacol; 2017 May; 46():201-209. PubMed ID: 28324830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tumor mechanism of Z-100, an immunomodulatory Arabinomannan extracted from Mycobacterium tuberculosis strain Aoyama B, on pulmonary metastases of B16F10 melanoma: restoration of helper T cell responses via suppression of glucocorticoid-genesis.
    Oka H; Emori Y; Sasaki H; Shiraishi Y; Yoshinaga K; Kurimoto T
    Microbiol Immunol; 2002; 46(5):343-51. PubMed ID: 12139394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of metastasis through inhibition of chitinase 3-like 1 expression by miR-125a-3p-mediated up-regulation of USF1.
    Kim KC; Yun J; Son DJ; Kim JY; Jung JK; Choi JS; Kim YR; Song JK; Kim SY; Kang SK; Shin DH; Roh YS; Han SB; Hong JT
    Theranostics; 2018; 8(16):4409-4428. PubMed ID: 30214629
    [No Abstract]   [Full Text] [Related]  

  • 8. Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice.
    Chaudhari AD; Gude RP; Kalraiya RD; Chiplunkar SV
    Mol Immunol; 2015 Dec; 68(2 Pt A):300-11. PubMed ID: 26442663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHI3L1 enhances melanoma lung metastasis
    Ma B; Kamle S; Akosman B; Khan H; Lee CM; Lee CG; Elias JA
    Front Immunol; 2022; 13():1056397. PubMed ID: 36618349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of chitinase 3-like-1 and semaphorin 7a in pulmonary melanoma metastasis.
    Ma B; Herzog EL; Lee CG; Peng X; Lee CM; Chen X; Rockwell S; Koo JS; Kluger H; Herbst RS; Sznol M; Elias JA
    Cancer Res; 2015 Feb; 75(3):487-96. PubMed ID: 25511377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory Th1 cells augment tumor-specific CTL following transcutaneous peptide immunization.
    Hosoi A; Takeda Y; Furuichi Y; Kurachi M; Kimura K; Maekawa R; Takatsu K; Kakimi K
    Cancer Res; 2008 May; 68(10):3941-9. PubMed ID: 18483280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy.
    Yang PS; Yu MH; Hou YC; Chang CP; Lin SC; Kuo IY; Su PC; Cheng HC; Su WC; Shan YS; Wang YC
    Theranostics; 2022; 12(1):340-361. PubMed ID: 34987649
    [No Abstract]   [Full Text] [Related]  

  • 13. Chitinase 3 like 1 suppresses the stability and activity of p53 to promote lung tumorigenesis.
    Park KR; Yun HM; Yoo K; Ham YW; Han SB; Hong JT
    Cell Commun Signal; 2020 Mar; 18(1):5. PubMed ID: 32127023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakdown of Th cell immune responses and steroidogenic CYP11A1 expression in CD4+ T cells in a murine model implanted with B16 melanoma.
    Oka H; Emori Y; Hayashi Y; Nomoto K
    Cell Immunol; 2000 Nov; 206(1):7-15. PubMed ID: 11161433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STING Agonist Combined to a Protein-Based Cancer Vaccine Potentiates Peripheral and Intra-Tumoral T Cell Immunity.
    Rossi M; Carboni S; Di Berardino-Besson W; Riva E; Santiago-Raber ML; Belnoue E; Derouazi M
    Front Immunol; 2021; 12():695056. PubMed ID: 34276686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8 T cells inhibit IgE via dendritic cell IL-12 induction that promotes Th1 T cell counter-regulation.
    Thomas MJ; Noble A; Sawicka E; Askenase PW; Kemeny DM
    J Immunol; 2002 Jan; 168(1):216-23. PubMed ID: 11751965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB-mediated inhibition of microRNA-149-5p regulates Chitinase-3-like 1 expression in human airway epithelial cells.
    Hübner K; Karwelat D; Pietsch E; Beinborn I; Winterberg S; Bedenbender K; Benedikter BJ; Schmeck B; Vollmeister E
    Cell Signal; 2020 Mar; 67():109498. PubMed ID: 31837465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of tumor-specific T cell-mediated immunity in dendritic cell-based vaccines by Mycobacterium tuberculosis heat shock protein X.
    Jung ID; Shin SJ; Lee MG; Kang TH; Han HD; Lee SJ; Kim WS; Kim HM; Park WS; Kim HW; Yun CH; Lee EK; Wu TC; Park YM
    J Immunol; 2014 Aug; 193(3):1233-45. PubMed ID: 24990079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model.
    Libreros S; Garcia-Areas R; Shibata Y; Carrio R; Torroella-Kouri M; Iragavarapu-Charyulu V
    Int J Cancer; 2012 Jul; 131(2):377-86. PubMed ID: 21866546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8
    Yin W; Song Y; Liu Q; Wu Y; He R
    Immunology; 2017 Oct; 152(2):287-297. PubMed ID: 28556970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.